Last 48 quarters of trend data · Healthcare · Eye & Dental Care
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 2447.57 | 51.07 | 43.42 | 50.52 | — | 37.22 | — | — | — | 46.54 | 79.35 | — | 48.77 | 102.92 | 109.52 | 291.74 | 101.13 | 83.99 | 69.41 | 105.89 | 228.25 |
| — | +37.2% | — | — | — | -20.0% | — | — | — | -54.8% | -27.5% | — | -51.8% | +22.5% | +57.8% | +175.5% | -55.7% | -68.5% | -67.4% | -59.9% | -19.3% | |
| P/S Ratio | 3.82 | 3.46 | 3.83 | 2.75 | 5.06 | 3.50 | 4.73 | 5.15 | 6.09 | 5.22 | 5.99 | 6.05 | 5.04 | 6.18 | 7.05 | 10.76 | 9.36 | 11.49 | 10.95 | 15.69 | 19.14 |
| — | -1.1% | -19.1% | -46.6% | -16.9% | -33.0% | -21.1% | -14.8% | +20.9% | -15.4% | -15.1% | -43.8% | -46.2% | -46.3% | -35.6% | -31.4% | -51.1% | -57.7% | -61.9% | -38.8% | -8.9% | |
| P/B Ratio | 3.63 | 3.07 | 3.92 | 2.92 | 3.40 | 3.75 | 2.49 | 2.51 | 3.00 | 4.32 | 5.80 | 4.77 | 3.98 | 5.24 | 7.36 | 9.34 | 7.13 | 10.92 | 11.87 | 14.36 | 17.47 |
| — | -18.1% | +57.3% | +16.4% | +13.2% | -13.3% | -57.1% | -47.4% | -24.6% | -17.5% | -21.2% | -49.0% | -44.2% | -52.0% | -38.0% | -34.9% | -59.2% | -57.1% | -61.1% | -40.9% | -10.9% | |
| P/FCF | 70.33 | 10.96 | 18.64 | — | — | 185.98 | — | — | — | — | — | 28.40 | 13.30 | — | — | — | — | 49.00 | 111.39 | — | 296.49 |
| — | -94.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -41.1% | -82.2% | — | +433.9% | |
| EV / EBITDA | 34.06 | 29.86 | 24.34 | 11.91 | — | 14.52 | — | — | — | 58.05 | 41.26 | — | 29.91 | 61.93 | 63.23 | 198.18 | 249.14 | 57.41 | 46.82 | 72.54 | 130.39 |
| — | +105.7% | — | — | — | -75.0% | — | — | — | -6.3% | -34.7% | — | -88.0% | +7.9% | +35.0% | +173.2% | +91.1% | -67.4% | -69.1% | -52.1% | -31.8% | |
| EV / EBIT | — | 37.83 | 29.90 | 28.42 | — | 12.17 | — | — | — | 32.82 | 53.59 | — | 33.39 | 75.14 | 73.89 | 277.45 | 607.34 | 61.95 | 49.68 | 78.54 | 155.86 |
| — | +210.7% | — | — | — | -62.9% | — | — | — | -56.3% | -27.5% | — | -94.5% | +21.3% | +48.7% | +253.3% | +289.7% | -68.5% | -69.8% | -53.6% | -31.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 76.2% | 70.9% | 74.5% | 72.2% | 75.7% | 82.2% | 74.0% | 65.8% | 64.7% | 77.3% | 79.2% | 78.9% | 79.6% | 79.2% | 76.6% | 78.3% | 77.7% | 79.5% | 78.8% | 77.9% | 76.3% |
| — | -13.8% | +0.7% | +9.8% | +17.0% | +6.3% | -6.6% | -16.7% | -18.8% | -2.4% | +3.4% | +0.8% | +2.4% | -0.3% | -2.7% | +0.4% | +1.9% | +2.4% | -0.2% | +1.1% | +2.3% | |
| Operating Margin | -19.2% | 6.5% | 10.8% | 18.6% | -18.9% | 19.5% | -67.6% | -134.8% | -57.0% | 6.4% | 12.0% | -2.9% | 13.6% | 7.8% | 9.3% | 3.8% | 1.5% | 18.0% | 21.0% | 19.2% | 12.5% |
| — | -66.5% | +116.0% | +113.8% | +66.8% | +204.3% | -662.6% | -4470.8% | -518.0% | -18.2% | +29.0% | -177.4% | +806.3% | -56.5% | -55.6% | -80.1% | -88.0% | +34.2% | +22.9% | +30.2% | +41.2% | |
| Net Margin | -33.6% | 6.7% | 8.6% | 5.6% | -31.7% | 9.4% | -37.9% | -127.3% | -69.9% | 11.3% | 7.5% | -4.3% | 10.2% | 6.0% | 6.6% | 3.7% | 9.1% | 13.5% | 16.1% | 15.2% | 8.3% |
| — | -28.7% | +122.7% | +104.4% | +54.7% | -16.8% | -609.0% | -2849.0% | -787.6% | +87.8% | +13.5% | -217.1% | +11.3% | -55.6% | -59.1% | -75.7% | +9.6% | +30.8% | +17.0% | +54.5% | +15.3% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -21.7% | 1.5% | 2.2% | 1.5% | -5.2% | 2.6% | -4.9% | -14.5% | -8.3% | 2.4% | 1.8% | -0.9% | 2.0% | 1.3% | 1.8% | 0.8% | 1.8% | 3.3% | 4.5% | 3.6% | 1.9% |
| — | -41.6% | +145.8% | +110.3% | +36.7% | +8.0% | -366.1% | -1591.9% | -508.7% | +81.2% | +5.1% | -206.8% | +13.7% | -60.3% | -61.3% | -77.6% | -8.0% | +33.1% | +18.7% | +47.9% | +11.8% | |
| ROA | -16.6% | 1.2% | 1.7% | 1.1% | -4.0% | 2.0% | -3.8% | -11.2% | -6.5% | 1.9% | 1.5% | -0.7% | 1.6% | 1.1% | 1.4% | 0.6% | 1.4% | 2.7% | 3.6% | 2.8% | 1.5% |
| — | -41.6% | +146.3% | +110.2% | +39.0% | +4.6% | -355.9% | -1547.6% | -504.7% | +79.9% | +4.0% | -205.2% | +12.3% | -60.3% | -60.7% | -76.5% | -2.0% | +36.9% | +17.2% | +44.4% | +8.6% | |
| ROIC | -13.2% | 1.5% | 3.0% | 5.4% | -3.7% | 6.5% | -10.6% | -17.0% | -7.0% | 1.5% | 3.9% | -0.8% | 3.0% | 1.6% | 2.3% | 0.7% | 0.3% | 5.9% | 10.5% | 8.8% | 6.6% |
| — | -76.2% | +128.0% | +131.5% | +47.7% | +324.6% | -371.8% | -2106.5% | -336.6% | -6.2% | +73.3% | -203.2% | +929.6% | -72.3% | -78.6% | -91.5% | -95.6% | -24.4% | -10.3% | -7.5% | +33.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.11 | 0.09 | 0.10 | 0.11 | 0.11 | 0.11 | 0.12 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.10 | 0.12 | 0.12 |
| — | -19.1% | -18.3% | +1.0% | +14.3% | +18.3% | +35.8% | +15.3% | +5.0% | -1.5% | -3.5% | -3.5% | +0.5% | +1.4% | -11.5% | -18.4% | -25.5% | -0.6% | +90.0% | +143.8% | +126.5% | |
| Debt / EBITDA | — | 3.81 | 2.65 | 1.90 | — | 1.91 | — | — | — | 5.38 | 2.70 | — | 3.08 | 4.70 | 3.23 | 8.14 | 13.21 | 2.02 | 1.72 | 2.43 | 3.84 |
| — | +99.3% | — | — | — | -64.5% | — | — | — | +14.4% | -16.4% | — | -76.6% | +132.2% | +88.1% | +235.1% | +243.6% | -24.3% | +55.0% | +100.1% | +73.4% | |
| Current Ratio | 4.55 | 4.68 | 4.66 | 5.12 | 4.55 | 5.21 | 4.94 | 4.78 | 5.23 | 5.99 | 5.80 | 5.84 | 5.62 | 6.11 | 6.05 | 6.65 | 6.03 | 6.55 | 6.37 | 6.65 | 5.56 |
| — | -10.2% | -5.6% | +7.2% | -13.1% | -12.9% | -14.8% | -18.1% | -6.8% | -2.1% | -4.2% | -12.2% | -6.8% | -6.7% | -5.0% | -0.0% | +8.4% | +16.2% | +7.4% | +7.5% | +6.0% | |
| Quick Ratio | 3.74 | 4.08 | 4.03 | 4.31 | 3.74 | 4.35 | 4.05 | 4.07 | 4.62 | 5.38 | 5.21 | 5.22 | 5.08 | 5.57 | 5.58 | 6.06 | 5.56 | 6.11 | 5.98 | 6.20 | 5.21 |
| — | -6.1% | -0.5% | +5.7% | -19.1% | -19.2% | -22.3% | -22.0% | -9.0% | -3.4% | -6.7% | -13.8% | -8.7% | -8.9% | -6.7% | -2.4% | +6.8% | +15.6% | +7.6% | +8.4% | +8.3% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2018.83 | 2325.67 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying STAA stock.
STAAR Surgical Company's current P/E is 2447.6x. The average P/E over the last 3 quarters is 48.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
STAAR Surgical Company's current operating margin is -19.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking STAAR Surgical Company's business trajectory between earnings reports.